MedTrace Logo

Collection of Biological Material From Pregnant Women in a Malarial Region

NCT01862783 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1270

Last updated 2019-11-25

No results posted yet for this study

Summary

Background:

\- Malaria is a disease caused by a parasite that infects the blood. It affects millions of people every year and frequently harms or kills pregnant woman and infants. Researchers are looking for treatments that may help pregnant women in areas of the world where malaria is common. To do so, they want to collect blood and other samples from pregnant women in south-central Uganda. They will also collect samples from newborn babies if the mother agrees to it.

Objectives:

\- To collect biological material such as blood samples from pregnant women and newborns.

Eligibility:

* Women between 14 and 45 years of age who are pregnant or are in labor.
* Participants will be from the Kalisizio area of south-central Uganda.

Design:

* Women who are pregnant will provide blood and urine samples.
* Women who are in labor will allow researchers to collect samples from their baby after the delivery. Samples will be taken of placenta tissue and umbilical cord blood. The baby will also be weighed and measured. Researchers will look at the baby's physical appearance and muscle strength.
* Treatment will not be offered as part of this study.

Conditions

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Michal Fried, Ph.D. · National Institute of Allergy and Infectious Diseases (NIAID)

Eligibility

Min Age
14 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-10
Primary Completion
2015-10-19
Completion
2016-03-15

Countries

  • Uganda

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01862783 on ClinicalTrials.gov